Mucinex® for Treatment of Filamentary Keratitis

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions

Filamentary Keratitis

Interventions

DRUG

Mucinex®

Trial Locations (1)

Massachusetts Eye and Ear Infirmary, Boston

All Listed Sponsors

lead

Massachusetts Eye and Ear Infirmary

OTHER

NCT02859246 - Mucinex® for Treatment of Filamentary Keratitis | Biotech Hunter | Biotech Hunter